Peptide questions · GHRP-2

GHRP-2 side effects: what studies and users report

Reviewed Evidence: ModeratePublished by PepVault

The side effects most commonly reported for GHRP-2 are increased appetite, water retention and fatigue, among 5 the library lists; its evidence in people comes from small studies without a control group and from clinical use.

The library holds no separate safety note for GHRP-2.

What is commonly reported with GHRP-2

  • Increased appetite
  • Water retention
  • Fatigue
  • Headache
  • Cortisol/prolactin increase

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other growth hormone compounds the library lists it for
EffectAlso listed for (of 13)
Increased appetite1: MK-677
Water retention9: Ipamorelin, CJC-1295 with DAC, CJC-1295 no DAC, Sermorelin and 5 more
Fatigue3: CJC-1295 with DAC, GHRP-6, Hexarelin
Headache4: Ipamorelin, CJC-1295 with DAC, CJC-1295 no DAC, Sermorelin
Cortisol/prolactin increaseNone: listed for GHRP-2 alone
A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Track GHRP-2 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Which GHRP-2 side effects the growth hormone group shares

Across the 14 growth hormone compounds in the library, the effects listed most often are water retention (10 of 14), headache (5 of 14), injection site reaction (5 of 14) and fatigue (4 of 14). GHRP-2 shares 4 of its 5 listed effects with at least one other growth hormone compound; cortisol/prolactin increase is listed for GHRP-2 alone.

Where the GHRP-2 reports come from

The library rates the evidence on GHRP-2 as moderate: animal studies plus some human data.

Of the library’s 3 research notes on GHRP-2, 1 rest on clinical data and 2 on community reports.

Our 6 study pages on GHRP-2: 6 clinical trials.

So the effects listed for GHRP-2 come from uncontrolled studies and use in people, not from placebo-controlled trials.

What our GHRP-2 study pages report on safety

GHRP-2: 30-day infusion raised GH and IGF-I in older adults

Clinical trial, human, 2004: Safety screening tests stayed normal. It tracked hormone and binding-protein levels plus safety screening tests, not health outcomes.

GHRP-2: height velocity rose to 6.1 cm/year in short children

Clinical trial, human, 1997: The spray was well tolerated.

Questions people ask

What are the side effects of GHRP-2?

The side effects most commonly reported for GHRP-2 are increased appetite, water retention and fatigue, among 5 the library lists; its evidence in people comes from small studies without a control group and from clinical use.

Do GHRP-2’s side effects come from human studies?

The library rates the evidence on GHRP-2 as moderate, and its evidence in people comes from small studies without a control group and from clinical use.

Which GHRP-2 side effects are its own?

Among the growth hormone compounds, the library lists cortisol/prolactin increase for GHRP-2 alone.

More on GHRP-2

Track it in the app

PepVault for iPhone

Track GHRP-2 in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo